WHO PQT-IVD Webinar – New Applicants to IVD Prequalification
IVD
A webinar for IVD manufacturers was held on 26 June.
News
REGISTRATION OPEN: 2024 annual joint UNICEF-UNFPA-WHO meeting with manufacturers and suppliers
IVD
Dear Colleagues,
WHO PQT-IVD Webinar – Product Dossier Assessment
IVD
A webinar for IVD manufacturers was held on Wednesday 29 May to share information about prequalificati
Performance evaluations for IVDs for monitoring of blood glucose in capillary blood and HbA1c PoC Assays
IVD
On 12 April 2024 WHO announced the expansion of prequalification of in vitro diagnostics to include diabetes.
Macleods’ artesunate 120 mg for injection prequalified
M
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
Mylan’s molnupiravir prequalified
M
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
HIV/AIDS EOI revised
M
The following products were added:
S Kant’s sulfadoxine/pyrimethamine tabl prequalified
M
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
Macleods’ flucytosine tablet prequalified
M
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
Ipca’s pyrimethamine/sulfadoxine dispersible tabl prequalified
M
WHO Prequalification Unit (PQT) added the below new products to its prequalified list:
Ipca’s pyrimethamine/sulfadoxine dispersible tabl + amodiaquine dispersible tabl prequalified
M
WHO Prequalification Unit (PQT) added the below new products to its prequalified list:
S Kant’s dispersible isoniazid tabl prequalified
M
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
22nd Invitation to Manufacturers of Antituberculosis Medicines to Submit an Expression of Interest (EOI) for Product Evaluation to the WHO Prequalification Unit
M
The Invitation to Manufacturers of Antituberculosis Medicines to su
First azithromycin prequalified
M
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
First NRT products prequalified
M
WHO Prequalification Unit (PQT) added the below new products to its prequalified list:
ViiV Healthcare’s abacavir/dolutegravir/lamivudine pediatric dispersible tabl prequalified
M
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
Merck’s praziquantel prequalified
M
WHO Prequalification Unit (PQT) added the below new p
Renata’s ethinylestradiol/levonorgestrel tabl prequalified
M
WHO Prequalification Unit (PQT) added the below new p
First cefiderocol prequalified
M
WHO Prequalification Unit (PQT) added the below new p
First miltefosine prequalified
M
WHO Prequalification Unit (PQT) added the below new p
First primaquine prequalified
M
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
Zydus’ daclatasvir products prequalified
M
WHO Prequalification Unit (PQT) added the below new products to its prequalified list:
Svizera’s isoniazid 300 mg tabl prequalified
M
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
Aurobindo’s molnupiravir prequalified
M
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
Zhejiang Huahai’s nirmatrelvir + ritonavir prequalified
M
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
Shouguang Fukang’s sulfamethoxazole/trimetoprim tablets prequalified
M
WHO Prequalification Unit (PQT) added the below new products to its prequalified list: